Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antibacterial activity of tamoxifen derivatives against methicillin-resistant Staphylococcus aureus

  • Molina Panadero, Irene
  • Falcón Torres, Javier
  • Hmadcha, Abdelkrim
  • Princiotto, Salvatore
  • Cutarella, Luigi
  • Mori, Mattia
© 2025 Molina Panadero, Falcón Torres, Hmadcha, Princiotto, Cutarella, Mori, Dallavalle, Christodoulou and Smani., The development of new antimicrobial therapeutic strategies requires urgent attention to prevent the tens of millions of deaths predicted to occur by 2050 as a result of multidrug-resistant (MDR) bacterial infections. This study aimed to discover new tamoxifen derivatives with antimicrobial potential, particularly targeting methicillin-resistant Staphylococcus aureus (MRSA). The minimum inhibitory concentration (MIC) of 22 tamoxifen derivatives was determined against S. aureus reference and MRSA strains using microdilution assays. The antibacterial effects of selected tamoxifen derivatives against MRSA (USA7 strain) were assessed through bacterial growth assays. Additionally, bacterial membrane permeability and molecular dynamics (MD) simulation assays were performed. The MIC of the tamoxifen derivatives against reference S. aureus and MRSA strains ranged from to 16 to >64 μg/mL. Bacterial growth assays demonstrated that tamoxifen derivatives 2, 5, and 6, the only compounds bearing the electron-donating hydroxyl group in the para position on both phenyl rings of the tamoxifen skeleton, dose-dependently reduced the growth of the USA7 strain. Moreover, treatment of MRSA with derivatives 2 and 5 resulted in a slight increase of membrane permeabilization. Extensive MD simulations on the interaction between 5 and 6 and the S. aureus membrane model suggest that the compounds do not act by destabilizing the membrane integrity. These findings suggest that tamoxifen derivatives exhibit antibacterial activity against MRSA, potentially broadening the spectrum of available drug treatments for combating antimicrobial-resistant S. aureus., This work was funded by the Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación, Fondo Europeo de Desarrollo Regional, MCIN/AEI/10.13039/501100011033/FEDER, and (Grant CEX2020-001088-M-20-5) UE (grant PID2022-136357OB-I00), the Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía (grant ProyExcel_00116), and the Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad (grant PI19/01009), cofinanced by the European Development Regional Fund (A way to achieve Europe, Operative Program Intelligent Growth, 2014–2020). This study has also received funding from the EU’s NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (project no. PE00000007, INF-ACT) (MM, LC)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001088-M-20-5)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The evolutionary replacement of restriction-modification by Ssp antiviral systems is associated with the distribution of prophages in the major clonal group of Acinetobacter baumannii

  • Moreno-Rodríguez, Antonio
  • Rubio, Alejandro
  • Garzón, Andrés
  • Smani, Younes
  • Pérez-Pulido, Antonio J.
Bacteriophages kill almost half of the world’s bacterial cells every day. In response, bacteria have developed anti-phage defense mechanisms that number in the dozens. Individual defense systems are gained and lost by genomes of the same species, depending on their fitness advantage. Thus, the combination of defense systems presented by the individual genomes may differ, and the collection of all of them is what is known as the pan-immune system of the species. Here, we have analyzed thousands of genomes of the bacterium Acinetobacter baumannii, an opportunistic pathogen of humans of great clinical concern, and we have found 81 different defense systems. By analyzing how these systems combine, we have found that more than half of the genomes lack the universal DNA-methylating restriction-modification systems and harbor an alternative innate Ssp system that performs DNA phosphorothioate modification. The presence of one or the other innate system may modulate the evolution of the genomes of this species, causing them to present a different profile of phages integrated into the bacterial genome. In fact, the most widespread strain of this bacterium worldwide, global clone 2, showed an Ssp system as its distinctive feature. We have also observed that the presence of many other defense systems is associated with the presence of a higher number of prophages, which could be because the prophage carries the system, or because the bacterium would not need these systems in environments where the phage is absent., This work has been funded by PID2023-150077OB-I00/AEI/10.13039/501100011033/ FEDER,UE (Agencia Estatal de Investigación/Ministry of Science and Innovation of the Spanish Government). This research was also supported by the Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación, Fondo Europeo de Desarrollo Regional, MCIN/AEI/10.13039/501100011033/FEDER, UE (grant CEX2020-001088-M-20-5). A.M.R. is supported by a doctoral fellowship, PRE2022-104318, from the Agencia Estatal de Investigación, Ministerio de Ciencia e Investigación., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001088-M-20-5), Peer reviewed